Decreasing sensor costs, artificial intelligence, and biomechanical modelling are used to improve patient outcomes and healthcare efficiency. Our first product widens access to quality testing for respiratory diseases like asthma and COPD.
Founder and CEO
Bioengineering PhD from Cambridge University.
Arete was born from his asthma struggles.
Over 7 years of experience in medical software.
Masters degree in signal processing.
We are looking for world-class people to join our team to join us in improving the lives of millions with chronic respiratory diseases. In particular, we are looking for people with skills in biomedical engineering, software algorithms, and medical device operations. We are also looking for clinical and business advisors, and would love to talk to anyone else who wants to help us!Contact Us
Chronic respiratory diseases reduce the quality of life of millions worldwide, and are a major cause of death. Health systems are increasingly strained. We believe improved care in the future can only come from more preventative and precision care. There is a great opportunity to apply advances in digital technologies to both improve care and health system efficiency.
Do you have something from your experiences that you think should be included in the next generation of respiratory tests? What's not working for you now? Please get in touch and help us do better!Contact Us
Arete's founder, Graeham Douglas, was a competitive swimmer for Cambridge University, but his struggles with asthma forced him to retire from the sport. Dr Douglas started Arete to apply his background in biomedical engineering to help improve care for people with chronic diseases.
Arete's name was inspired by the book Zen and the Art of Motorcycle Maintenance, meaning a wholistic quality (Greek). We view chronic disease management as requiring a wholistic view of the individual. The ambiguity with the French meaning of the word (to stop) is intentional.